✦ LIBER ✦

The Use of Biomarkers for the Evaluation and Treatment of Patients with Acute Coronary Syndromes

✍ Scribed by Saenger, Amy K.; Jaffe, Allan S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic evaluation of rivaroxaba

✍ Gopalakrishnan, Lakshmi; Kumar, Varun; Kohli, Payal; Singh, Priyamvada; Rastogi, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 385 KB

Appraisal of Myeloperoxidase for Evaluat

✍ David A. Morrow 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The value of novel serum biomarkers in r

✍ Turgay Celik; Murat Celik; U. Cagdas Yuksel; Baris Bugan; Atila Iyisoy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Pharmacokinetic evaluation of argatroban

✍ Cruz-González, Ignacio; López-Jiménez, Rosana; Perez-Rivera, Angel; Yan, Bryan P 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 254 KB

Novel Biomarkers for the Prediction of A

✍ Gonzales, Kristen; Adolphe, Allen Barry; Skipper, Betty 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 52 KB

Treatment of Acute Coronary Syndromes in

✍ Savonitto, Stefano; Morici, Nuccia; De Servi, Stefano 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 483 KB